Live feed
·
PRReleasevia Quantisnow
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene

ByQuantisnow·Wall Street's wire, on your screen.
BGLC· BioNexus Gene Lab Corp
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BGLC (BioNexus Gene Lab Corp) and more on Quantisnow.